0,798  0,006  Respiratory analeptic
0,802  0,011  Caspase 9 stimulant
0,722  0,004  Cardiodepressant
0,715  0,004  Muscle relaxant
0,701  0,003  Skeletal muscle relaxant
0,700  0,018  Antineoplastic (lung cancer)
0,683  0,008  5 Hydroxytryptamine release stimulant
0,636  0,006  CYP2C19 inhibitor
0,622  0,003  Dopamine D1 antagonist
0,617  0,012  Analeptic
0,608  0,012  Spasmolytic
0,601  0,010  Caspase 3 stimulant
0,581  0,008  CYP2D6 inhibitor
0,564  0,005  Dopamine antagonist
0,571  0,026  Antineoplastic (colorectal cancer)
0,569  0,025  Antineoplastic (colon cancer)
0,540  0,014  Antineoplastic (non-small cell lung cancer)
0,569  0,056  Apoptosis agonist
0,509  0,005  Dopamine D2 antagonist
0,506  0,010  Sedative
0,504  0,012  Antimitotic
0,498  0,006  5 Hydroxytryptamine 2 antagonist
0,499  0,008  Tubulin antagonist
0,496  0,005  Male reproductive disfunction treatment
0,489  0,004  Alpha 2 adrenoreceptor antagonist
0,522  0,045  Antineoplastic (solid tumors)
0,513  0,051  Antineoplastic (breast cancer)
0,468  0,007  Alpha adrenoreceptor antagonist
0,490  0,032  Histamine release inhibitor
0,460  0,005  5 Hydroxytryptamine 2A antagonist
0,463  0,019  Antineoplastic (glioblastoma multiforme)
0,464  0,025  Antineoplastic (glioma)
0,463  0,025  Antineoplastic (brain cancer)
0,460  0,023  Antineoplastic (multiple myeloma)
0,438  0,012  Cyclic AMP phosphodiesterase inhibitor
0,450  0,031  Antineoplastic (melanoma)
0,422  0,004  Dopamine D3 antagonist
0,452  0,035  Antidepressant
0,455  0,040  Prostate cancer treatment
0,429  0,018  Sigma receptor agonist
0,443  0,036  Antineoplastic (ovarian cancer)
0,443  0,041  Mood disorders treatment
0,410  0,009  Cholinergic
0,422  0,025  Hypoxia-inducible factor 1 alpha inhibitor
0,400  0,007  Erectile dysfunction treatment
0,395  0,004  LDLR expression enhancer
0,395  0,007  Acetylcholinesterase inhibitor
0,418  0,030  Vasodilator, coronary
0,395  0,012  5 Hydroxytryptamine antagonist
0,410  0,030  NOS2 expression inhibitor
0,422  0,057  Antileukemic
0,368  0,007  Topoisomerase I inhibitor
0,395  0,037  Antineoplastic (cervical cancer)
0,362  0,005  Alpha 2b adrenoreceptor antagonist
0,361  0,007  Butyrylcholinesterase inhibitor
0,350  0,009  Neurotrophic factor enhancer
0,354  0,015  MAO inhibitor
0,371  0,035  DNA damaging
0,340  0,008  5 Hydroxytryptamine 1A antagonist
0,353  0,021  P-glycoprotein inhibitor
0,336  0,006  Heat shock protein 90 antagonist
0,363  0,034  Antineoplastic (lymphoma)
0,370  0,042  CYP3A4 inhibitor
0,345  0,016  Antineoplastic (squamous cell carcinoma)
0,334  0,005  Alpha 2a adrenoreceptor antagonist
0,383  0,061  Vasodilator, peripheral
0,334  0,012  MAO A inhibitor
0,329  0,010  DNA intercalator
0,321  0,009  5 Hydroxytryptamine 1 antagonist
0,345  0,037  Antineoplastic (renal cancer)
0,355  0,050  CYP1A2 substrate
0,318  0,015  Antiischemic, cerebral
0,304  0,004  Alpha tubulin antagonist
0,340  0,041  Tumour necrosis factor alpha release inhibitor
0,338  0,041  Antineoplastic (small cell lung cancer)
0,353  0,057  CYP2D6 substrate
0,338  0,046  Antineurogenic pain
0,308  0,017  Topoisomerase II inhibitor
0,314  0,032  Antiparkinsonian, rigidity relieving
0,370  0,090  TNF expression inhibitor
0,326  0,050  CYP1A2 inhibitor
0,280  0,008  Phobic disorders treatment
0,276  0,005  Beta tubulin antagonist
0,332  0,067  Hepatic disorders treatment
0,275  0,013  Alpha 1 adrenoreceptor antagonist
0,277  0,016  5 Hydroxytryptamine 2B antagonist
0,274  0,016  NADPH oxidase inhibitor
0,296  0,044  Antineoplastic (sarcoma)
0,292  0,040  Antihypertriglyceridemic
0,314  0,066  Antipsychotic
0,346  0,102  15-Lipoxygenase inhibitor
0,270  0,026  Antineoplastic (carcinoma)
0,251  0,008  Calcium antagonist
0,343  0,109  Antiparkinsonian
0,267  0,039  Hepatoprotectant
0,303  0,075  Anxiolytic
0,272  0,052  5 Hydroxytryptamine 1E antagonist
0,285  0,066  UGT1A9 substrate
0,231  0,013  Alpha 2c adrenoreceptor antagonist
0,240  0,030  Antiparkinsonian, tremor relieving
0,231  0,022  Uterine stimulant
0,233  0,030  Acetylcholine M1 receptor antagonist
0,267  0,065  Antineoplastic (bladder cancer)
0,342  0,141  MAP kinase 1 inhibitor
0,204  0,007  CDC-like kinase 3 inhibitor
0,201  0,006  Phosphodiesterase V inhibitor
0,221  0,026  CDC-like kinase 1 inhibitor
0,227  0,033  Protein kinase stimulant
0,267  0,075  Antioxidant
0,242  0,050  Abortion inducer
0,228  0,038  UGT1A3 substrate
0,248  0,058  Amyloid beta aggregation inhibitor
0,257  0,069  Antineoplastic (liver cancer)
0,265  0,077  Aldehyde oxidase inhibitor
0,221  0,034  Lipid peroxidase inhibitor
0,200  0,014  Antineoplastic alkaloid
0,193  0,007  Glutamate decarboxylase inhibitor
0,233  0,049  Pneumotoxic
0,197  0,014  Breast cancer-resistant protein inhibitor
0,185  0,004  Heat shock protein 90 beta antagonist
0,222  0,041  Tumour necrosis factor antagonist
0,286  0,108  Antiprotozoal (Plasmodium)
0,246  0,069  Cytostatic
0,181  0,005  Phosphodiesterase 11A inhibitor
0,181  0,005  Phosphodiesterase XI inhibitor
0,252  0,076  Antipyretic
0,197  0,025  MAO B inhibitor
0,178  0,008  Phosphodiesterase 5A inhibitor
0,263  0,096  Antiischemic
0,266  0,100  Antineoplastic (osteosarcoma)
0,190  0,026  Antiadrenergic
0,274  0,111  Transcription factor NF kappa B inhibitor
0,187  0,026  Adrenaline antagonist
0,224  0,064  VCAM1 expression inhibitor
0,204  0,047  Heat shock protein 90 alpha antagonist
0,198  0,044  Toxic, respiratory center
0,191  0,040  Carcinogenic, group 1
0,168  0,020  Topoisomerase II alpha inhibitor
0,266  0,120  CYP3A4 substrate
0,155  0,009  Acetylcholine M4 receptor antagonist
0,216  0,073  Antineoplastic enhancer
0,181  0,037  Bipolar disorder treatment
0,145  0,003  Factor III inhibitor
0,239  0,099  CYP2C19 substrate
0,189  0,050  Antineoplastic (bone cancer)
0,160  0,022  Alpha 1a adrenoreceptor antagonist
0,177  0,047  Genotoxic
0,144  0,016  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,193  0,067  Chemopreventive
0,223  0,099  Tyrosine 3 hydroxylase inhibitor
0,211  0,091  Antineoplastic (lymphocytic leukemia)
0,199  0,080  Psychostimulant
0,189  0,072  Nitric oxide antagonist
0,194  0,079  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,233  0,119  12-Lipoxygenase inhibitor
0,225  0,111  Radiosensitizer
0,166  0,053  Toll-Like receptor 9 antagonist
0,263  0,152  Antiprotozoal
0,222  0,111  Antineoplastic (pancreatic cancer)
0,208  0,098  Vasodilator
0,114  0,004  Ryanodine receptor antagonist
0,204  0,094  Free radical scavenger
0,186  0,084  Antiarrhythmic
0,187  0,085  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,164  0,064  Melanin inhibitor
0,168  0,070  UGT2B10 substrate
0,258  0,161  Antineoplastic (myeloid leukemia)
0,110  0,014  Alpha 1 adrenoreceptor agonist
0,103  0,009  Glutamate (mGluR7) antagonist
0,113  0,023  Dopamine D4 antagonist
0,140  0,050  Acetylcholine muscarinic antagonist
0,150  0,066  Attention deficit/hyperactivity disorder treatment
0,108  0,024  Dopamine agonist
0,190  0,107  Antiprotozoal (Leishmania)
0,145  0,063  Antifungal enhancer
0,151  0,069  UGT2B15 substrate
0,092  0,010  Dopamine D5 antagonist
0,106  0,025  Alpha adrenoreceptor agonist
0,160  0,079  UGT1A4 substrate
0,109  0,029  ATPase (Vacuolar H+) inhibitor
0,124  0,044  Multidrug resistance-associated protein 1 inhibitor
0,134  0,054  Antineoplastic (uterine cancer)
0,173  0,094  UGT1A1 substrate
0,099  0,021  Phosphodiesterase VI inhibitor
0,191  0,114  RNA-directed DNA polymerase inhibitor
0,102  0,025  5 Hydroxytryptamine 7 antagonist
0,106  0,030  Histidine decarboxylase inhibitor
0,086  0,010  5 Hydroxytryptamine 7 agonist
0,099  0,023  Alpha 1d adrenoreceptor antagonist
0,130  0,055  DNA repair enzyme inhibitor
0,134  0,060  Acetylcholine antagonist
0,135  0,062  Cholinergic antagonist
0,198  0,125  DNA synthesis inhibitor
0,106  0,033  Alpha 1b adrenoreceptor antagonist
0,107  0,040  Phosphodiesterase 6D inhibitor
0,163  0,097  Cytotoxic
0,158  0,093  Antineoplastic (gastric cancer)
0,090  0,027  Acetylcholine M5 receptor agonist
0,172  0,110  VEGF expression inhibitor
0,088  0,026  Female sexual dysfunction treatment
0,112  0,050  Dementia treatment
0,162  0,101  Anesthetic general
0,104  0,043  5 Hydroxytryptamine 2C antagonist
0,067  0,008  Endothelin receptor antagonist
0,126  0,067  Papain-like protease (SARS coronavirus) inhibitor
0,085  0,026  Acetylcholine M2 receptor antagonist
0,237  0,179  CYP2C9 inhibitor
0,107  0,049  Vascular dementia treatment
0,119  0,062  Microtubule formation inhibitor
0,152  0,098  ATPase inhibitor
0,077  0,025  5 Hydroxytryptamine 5A antagonist
0,068  0,019  5 Hydroxytryptamine 1B agonist
0,151  0,104  Platelet adhesion inhibitor
0,071  0,025  Potassium channel (Ca-activated) blocker
0,068  0,023  Bcl-xL inhibitor
0,107  0,063  DOPA decarboxylase inhibitor
0,154  0,110  Clk dual-specificity kinase inhibitor
0,087  0,044  T cell inhibitor
0,055  0,013  Phosphodiesterase 6C inhibitor
0,072  0,029  Acetylcholine M5 receptor antagonist
0,069  0,027  5 Hydroxytryptamine 5 antagonist
0,081  0,039  Antitreponemal
0,169  0,128  Antihypercholesterolemic
0,171  0,131  5 Hydroxytryptamine 3E antagonist
0,128  0,087  Antimutagenic
0,161  0,121  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,112  0,071  Antitussive
0,089  0,049  mTOR complex 2 inhibitor
0,044  0,006  Endothelin B receptor antagonist
0,151  0,114  Pyruvate kinase inhibitor
0,196  0,160  5 Hydroxytryptamine uptake stimulant
0,213  0,177  FMO1 substrate
0,074  0,038  5 Hydroxytryptamine 1B antagonist
0,182  0,148  Proliferative diseases treatment
0,041  0,008  Endothelin A receptor antagonist
0,079  0,047  MAP kinase 7 inhibitor
0,095  0,063  Obsessive-compulsive disorder treatment
0,141  0,110  Sensitization
0,109  0,078  Sphingosine 1-phosphate receptor 2 agonist
0,080  0,049  Focal adhesion kinase 1 inhibitor
0,054  0,024  Dopamine D2 agonist
0,066  0,036  Alpha 2 adrenoreceptor agonist
0,086  0,058  Carcinogenic, group 2A
0,191  0,163  Prostaglandin dehydrogenase inhibitor
0,145  0,118  Antimigraine
0,067  0,041  5 Hydroxytryptamine uptake inhibitor
0,038  0,013  Phosphodiesterase 6B inhibitor
0,032  0,008  Dopamine D1 agonist
0,251  0,227  5 Hydroxytryptamine release inhibitor
0,145  0,122  Non-steroidal antiinflammatory agent
0,042  0,021  Vesicle monoamine transporter inhibitor
0,106  0,086  Antiseptic
0,184  0,166  UGT2B4 substrate
0,196  0,179  ICAM1 expression inhibitor
0,026  0,012  Phosphodiesterase 6H inhibitor
0,026  0,012  Phosphodiesterase 6G inhibitor
0,104  0,089  Antiviral (Hepatitis B)
0,041  0,027  Acid-sensing ion channel blocker
0,045  0,032  5 Hydroxytryptamine 1A agonist
0,168  0,154  Cardiotonic
0,099  0,087  Activin receptor-like kinase 4 inhibitor
0,074  0,062  Acetylcholine nicotinic antagonist
0,082  0,071  Tocolytic
0,165  0,154  Hypoglycemic
0,100  0,089  Alkylator
0,147  0,138  Dependence treatment
0,048  0,040  5 Hydroxytryptamine 2 agonist
0,076  0,069  Inducible nitric-oxide synthase inhibitor
0,105  0,099  Phosphodiesterase inhibitor
0,096  0,091  Electron transport complex I inhibitor
0,103  0,098  Cyclooxygenase 3 inhibitor
0,060  0,055  5 Hydroxytryptamine agonist
0,045  0,041  Topoisomerase II beta inhibitor
0,118  0,114  Antiviral (Herpes)
0,116  0,112  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,056  0,054  5 Hydroxytryptamine 1D antagonist
0,046  0,046  Melanin-concentrating hormone receptor 1 antagonist
0,022  0,021  Phosphodiesterase 6A inhibitor

